Literature DB >> 11444905

Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors.

J Luan1, Y Furuta, J Du, A Richmond.   

Abstract

CXC chemokines, macrophage inflammatory protein-2 (MIP-2) and KC, (a cloning designation based on ordinate and abscissa position) as well as the CXC chemokine receptor, CXCR2, are expressed in a variety of cells and tissues in adult mice. Targeted deletion of the gene encoding murine CXCR2 does not result in obvious changes in the development of the organ system of the mouse, though the CXCR2-/- mouse is compromised with regard to its ability to resist infection, heal wounds, and maintain homeostasis when challenged with microbes and/or chemicals. In an attempt to develop insight into additional possible subtle roles of CXCR2 and its ligands in the development of the mouse, we examined the expression of MIP-2, KC, CXCR2, as well as the Duffy antigen binding protein for chemokines during embryonic (p.c.) days 11.5 through 14.5 in the mouse. We observed strong correlation between the expression of MIP-2 and CXCR2 in the developing brain, cardiovascular system and condensing mesenchyme between 11.5 and 13.5 days. Moreover, the expression of KC was parallel to the expression of the Duffy antigen binding protein for chemokines with regard to temporal pattern and tissue localization. MIP-2 and CXCR2 are highly expressed in the brain, first in the cerebellum and in the head mesenchyme, the meninges and the floor plate, and by 14.5 days are also present in the telencephalon, thalamus and hypothalamus. In the developing brain KC and Duffy were prominently expressed in the neuronal tracts, the forebrain, sympathetic ganglia, and along the periphery of the neural tube. However, KC and Duffy were less prevalent in the developing cardiovascular system, lung and other organs, muscle and bone, than are CXCR2 and MIP-2. These data suggest that the roles for these chemokines and their receptors during development may be more significant than was initially thought based upon the phenotype of the mice with targeted deletion of CXCR2 and Duffy. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444905      PMCID: PMC5433622          DOI: 10.1006/cyto.2001.0882

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

Review 1.  Multiple chemotactic factors: fine control or redundancy?

Authors:  M N Devalaraja; A Richmond
Journal:  Trends Pharmacol Sci       Date:  1999-04       Impact factor: 14.819

2.  Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene.

Authors:  H Luo; A Chaudhuri; K R Johnson; K Neote; V Zbrzezna; Y He; A O Pogo
Journal:  Genome Res       Date:  1997-09       Impact factor: 9.043

3.  Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties.

Authors:  A Wuyts; N Van Osselaer; A Haelens; I Samson; P Herdewijn; A Ben-Baruch; J J Oppenheim; P Proost; J Van Damme
Journal:  Biochemistry       Date:  1997-03-04       Impact factor: 3.162

4.  Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines.

Authors:  T Tang; J D Owen; J Du; C L Walker; A Richmond
Journal:  DNA Seq       Date:  1998

5.  The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.

Authors:  S K Ahuja; P M Murphy
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

6.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.

Authors:  G Cacalano; J Lee; K Kikly; A M Ryan; S Pitts-Meek; B Hultgren; W I Wood; M W Moore
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

7.  BMP4 is essential for lens induction in the mouse embryo.

Authors:  Y Furuta; B L Hogan
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

8.  Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors.

Authors:  D M Araujo; C W Cotman
Journal:  Brain Res       Date:  1993-01-08       Impact factor: 3.252

9.  Chemokine binding and activities mediated by the mouse IL-8 receptor.

Authors:  J Lee; G Cacalano; T Camerato; K Toy; M W Moore; W I Wood
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia.

Authors:  M Lacy; J Jones; S R Whittemore; D L Haviland; R A Wetsel; S R Barnum
Journal:  J Neuroimmunol       Date:  1995-08       Impact factor: 3.478

View more
  16 in total

Review 1.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Authors:  Anne L Bishop; Bharathi Patimalla; Andrew Camilli
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation.

Authors:  Janet S Lee; Mark M Wurfel; Gustavo Matute-Bello; Charles W Frevert; Matthew R Rosengart; Mrunalini Ranganathan; Venus W Wong; Tarah Holden; Steve Sutlief; Ann Richmond; Stephen Peiper; Thomas R Martin
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 4.  Developmental biology of the meninges.

Authors:  Krishnakali Dasgupta; Juhee Jeong
Journal:  Genesis       Date:  2019-03-13       Impact factor: 2.487

5.  Reactive oxygen species and IRF1 stimulate IFNα production by proximal tubules during ischemic AKI.

Authors:  Pamela D Winterberg; Yanxia Wang; Keng-Mean Lin; John R Hartono; Glenn T Nagami; Xin J Zhou; John M Shelton; James A Richardson; Christopher Y Lu
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-08

6.  Developmental changes in circulating IL-8/CXCL8 isoforms in neonates.

Authors:  Akhil Maheshwari; Nikolai N Voitenok; Svetlana Akalovich; Sadiq S Shaik; David A Randolph; Brian Sims; Rakesh P Patel; Cheryl R Killingsworth; Michael B Fallon; Robin K Ohls
Journal:  Cytokine       Date:  2009-02-15       Impact factor: 3.861

7.  Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting.

Authors:  Consuelo Walss-Bass; Robert Suchting; Rene L Olvera; Douglas E Williamson
Journal:  J Affect Disord       Date:  2018-03-12       Impact factor: 4.839

Review 8.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

9.  Induction of CXC chemokines in human mesenchymal stem cells by stimulation with secreted frizzled-related proteins through non-canonical Wnt signaling.

Authors:  David S Bischoff; Jian-Hua Zhu; Nalini S Makhijani; Dean T Yamaguchi
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

10.  Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in mice.

Authors:  Qingshan Wang; Esteban Oyarzabal; Belinda Wilson; Li Qian; Jau-Shyong Hong
Journal:  Clin Sci (Lond)       Date:  2015-06-22       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.